Altogether, our study highlights for the first time that ceramide metabolism alterations contribute to TNF-induced melanoma cell dedifferentiation and opens new avenues for developing original therapeutic strategies aiming at reducing melanoma progression and resistance to therapies. This evidence concerns the gene TNF and melanoma.